Detalles de la búsqueda
1.
Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials.
Pharm Stat
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38591424
2.
Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies.
Pharm Stat
; 22(3): 475-491, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606496
3.
Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine.
J Infect Dis
; 226(11): 1943-1948, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662415
4.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283213
5.
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
Rheumatology (Oxford)
; 60(3): 1226-1233, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32910152
6.
Assurance in vaccine efficacy clinical trial design based on immunological responses.
Biom J
; 63(7): 1434-1443, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34254347
7.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med
; 375(11): 1019-32, 2016 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27626517
8.
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
N Engl J Med
; 372(22): 2087-96, 2015 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25916341
9.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol
; 13(1): 100-10, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075170
10.
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Hum Vaccin Immunother
; 17(7): 2050-2057, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606577
11.
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine.
Hum Vaccin
; 6(12): 1054-61, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21157180
12.
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials.
Hum Vaccin Immunother
; 16(11): 2628-2633, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347767
13.
Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.
Vaccine
; 37(43): 6262-6267, 2019 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537443
14.
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Hum Vaccin Immunother
; 15(12): 2865-2872, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216205
15.
Statistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development.
Stat Methods Med Res
; 25(6): 2811-2826, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24845724
16.
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
Lancet
; 364(9447): 1757-65, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15541448
17.
Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Clin Vaccine Immunol
; 22(4): 361-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651922
18.
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Hum Vaccin Immunother
; 10(8): 2147-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424918
19.
Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults.
Hum Vaccin Immunother
; 9(7): 1425-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23584252
20.
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up.
Hum Vaccin Immunother
; 8(3): 390-7, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22327492